The basic difference is that for toxic substances for which we have information that they're carcinogenic, mutagenic, toxic to reproduction, or very persistent and very bioaccumulative, the European Union takes that subset of all toxic substances and says, “For these cases, we're not going to put the burden on government to demonstrate that there's a harm to human health and the environment.” It says to industry, “Look, we know that these substances have these toxic properties. What we want you to do is to provide evidence to us that these substances can be used safely, and that there are no feasible alternatives.”
It's really reversing the burden of proof for those substances. What that has enabled the European Union to do is to move more expeditiously in getting these toxic substances out of our economy, out of our society, out of our environment, and out of our bodies. I would like to clarify—